Clinical Trial Update: Haematopoietic Stem Cell Transplantation (HSCT) in Comparison to Conventional Consolidation Therapy for Patients With Acute Myeloid Leukemia (AML) (Intermediate Risk) </= 60y. After First CR [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing hematopoietic stem cell transplantation to conventional consolidation therapy in intermediate-risk acute myeloid leukemia patients und…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: University Hospital Carl Gustav Carus | Conditions: Leukemia, Myeloid, Acute | Phase 3 | Status: TERMINATED